<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01355809</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-07-C2-017</org_study_id>
    <nct_id>NCT01355809</nct_id>
  </id_info>
  <brief_title>Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation</brief_title>
  <acronym>rehabilitate</acronym>
  <official_title>Single Centre, Exploratory, Phase II, Cross-over, Randomised Trial, Evaluating the Effect of Spontaneously Breathing He/O2 65%/35% to Either Spontaneously Breathing N2/O2 65%35% or Non-Invasive Ventilated N2/O2 65%/35% on a 6 Minute Walk Test in Severe COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asklepios Kliniken Hamburg GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Air Liquide SA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate effects of inspired gas mixtures on the distance
      walked by patients with severe Chronic Obstructive Pulmonary Disease (COPD) during a
      Six-Minute Walk test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the purpose of this study is to evaluate the distance walked by patients with severe Chronic
      Obstructive Pulmonary Disease (COPD) during a Six-Minute Walk test (6MWT) while breathing
      Helium/Oxygen 65%/35% compared to either breathing Nitrogen/Oxygen 65%/35% or receiving
      Non-Invasive Ventilation (NIV) with a FiO2 of 0.35 and to evaluate exercise related symptoms
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to low recruitment rate the sponsor decided to discontinue the study.
  </why_stopped>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance walked</measure>
    <time_frame>6 minutes</time_frame>
    <description>evaluate the distance walked by patients during a Six-Minute Walk Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the safety of inhalation Helium/Oxygen</measure>
    <time_frame>6 minutes</time_frame>
    <description>evaluate the safety of the administration of Helium/Oxygen 65%/35%</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Inhalation Nitrogen/Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nitrogen/Oxygen (65%/35%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalation Helium/Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Helium/Oxygen (65%/35%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalation gas</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medicinal oxygen 100% via NIV with FiO2 of 0.35</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhalation gas</intervention_name>
    <description>Inhalated gas, medicinal oxygen 100% via NIV with Fi O2 0.35, one time by random, 6 minutes</description>
    <arm_group_label>Inhalation gas</arm_group_label>
    <other_name>Experimental</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhalation Nitrogen/Oxygen</intervention_name>
    <description>Inhalated gas, Nitrogen/Oxygen (65%/35%), one time by random, 6 minutes</description>
    <arm_group_label>Inhalation Nitrogen/Oxygen</arm_group_label>
    <other_name>Active Comparator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhalation Helium/Oxygen</intervention_name>
    <description>Inhalated gas, Helium/Oxygen (65%/35%) one time by random, 6 minutes</description>
    <arm_group_label>Inhalation Helium/Oxygen</arm_group_label>
    <other_name>Experimental He</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged &gt;= 45 and &lt;= 75 years old

          -  Patient with documented clinical diagnosis of stage III/IV COPD

          -  Patient with stable COPD defined by no significant increase in COPD medication, no
             treatment for COPD in an emergency, no acute intensive care setting and no intake of
             antibiotics in the four weeks prior to selection

        Exclusion Criteria:

          -  Inability or contra-indication to perform pulmonary function tests

          -  Inability or contra-indication to perform the 6MWT with a trolley

          -  Any contra-indication to receive NIV

          -  Obese patient having a Body Mass Index (BMI) &gt; 35

          -  Pregnant or lactating woman

          -  Female or chil-bearing potential with lack of efficient contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl HAUSSINGER, Prof Dr Med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asklepios fachkliniken München-Gauting</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asklepios Fachkliniken München-Gauting</name>
      <address>
        <city>Gauting</city>
        <zip>82131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2011</study_first_submitted>
  <study_first_submitted_qc>May 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2011</study_first_posted>
  <last_update_submitted>August 8, 2014</last_update_submitted>
  <last_update_submitted_qc>August 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Six-Minute Walk Test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

